eClinical Tech News

Iovance Biotherapeutics granted inducement stock options covering 43,150 shares to four new non-executive employees, effective December 18, 2025, at...

Boehringer Ingelheim has secured FDA approval for Jascayd (nerandomilast) tablets to treat progressive pulmonary fibrosis (PPF) in adults, the...

Centessa Pharmaceuticals reported positive Phase 2a results for its oral OX2R agonist, ORX750, across narcolepsy type 1, narcolepsy type...

Pharming Group posted a 30% year-over-year revenue increase to $97.3 million in Q3 2025 and lifted full-year guidance to...

Trethera has secured a $2.7 million NIH Small Business Innovation Research grant to evaluate its first-in-class DCK inhibitor, TRE-515,...

Athira Pharma has licensed global rights (excluding Asia and certain Middle Eastern countries) to lasofoxifene from Sermonix Pharmaceuticals, positioning...

Outlook Therapeutics posted fiscal 2025 results with its first commercial revenue from Lytenava, an ophthalmic formulation of bevacizumab for...

Sai Life Sciences has published its 2024–25 sustainability report, aligning with GRI Universal Standards 2021 and SASB, and outlining...

Rakovina Therapeutics will use JPM Week 2026 to court partners and investors on the back of new preclinical data...

Nanobiotix has closed a non-dilutive royalty financing with Healthcare Royalty for up to $71 million, securing $50 million upfront...